dTDI During a SBT to Predict Extubation Failure in Preterm Infants

July 13, 2024 updated by: Wang Jianhui

Diaphragmatic Tissue Doppler Imaging During a Spontaneous Breathing Trial to Predict Extubation Failure in Preterm Infants

Weaning from mechanical ventilation is a critical issue and the diaphragmatic disfunction has been demonstrated to play an important role in extubation failure. the aim of present investigation is to evaluate diaphragmatic excursion velocity during in patients undergoing spontaneous breathing trial through tissue Doppler analysis in both inspiration and expiration.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Chongqing
      • Chongqing, Chongqing, China, 400014
        • Recruiting
        • Children's Hospital of Chongqing Medical University
        • Contact:
        • Principal Investigator:
          • Shuo Tang, Master

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

premature infants with gestational age <32 weeks and supported by invasive mechanical ventilation ≥48 hours

Description

Inclusion Criteria:

  • premature infants with gestational age <32 weeks and supported by invasive mechanical ventilation ≥48 hours
  • All the indications for extubation are met:cough or vomiting due to spontaneous breathing and sputum aspiration; ventilator parameters in recent 24 hours: MAP < 8cmH2O, RR < 30 times/min, FiO2 < 30%; Arterial blood gas: pH > 7.25, (PaCO2< 60mmHg, BE < 8mmol/L, oxygen saturation > 90%
  • a successful SBT
  • parents or legal guardians sign informed consent to attend this study

Exclusion Criteria:

  • accidental extubation
  • chest CT or bronchoscopy during hospitalization indicated congenital airway dysplasia
  • complex congenital heart disease
  • congenital metabolic diseases, neuromuscular diseases
  • severe brain injury
  • surgical mechanical ventilation
  • give up before extubation;
  • pneumothorax or pleural effusion
  • no consent is signed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
the failure group
Re-intubation within 48 h after passing the SBT was defined as failed weaning.
dTDI was performed at the end of the SBT to assess excursion, velocity, and acceleration.
the success group
Extubation and invasive mechanical ventilation was not needed within 48 h after extubation was defined as successful weaning.
dTDI was performed at the end of the SBT to assess excursion, velocity, and acceleration.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in diaphragmatic displacement velocity
Time Frame: an average of 20 minutes
Inspiratory and expiratory diaphragmatic displacement velocity evaluated with tissue doppler during the assisted ventilation modality which preceded the trial, during the spontaneous breathing trial and in spontaneous breathing.
an average of 20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gas exchange - arterial carbon dioxide tension
Time Frame: through each trial completion, an average of 20 minutes
Arterial blood gases sample
through each trial completion, an average of 20 minutes
Diaphragmatic acceleration and deceleration
Time Frame: an average of 20 minutes
Diaphragmatic acceleration and deceleration evaluated with tissue doppler during the assisted ventilation modality which preceded the trial, during the spontaneous breathing trial and in spontaneous breathing.
an average of 20 minutes
Gas exchange - pH
Time Frame: an average of 20 minutes
Arterial blood gases sample
an average of 20 minutes
Gas exchange - arterial oxygen tension
Time Frame: an average of 20 min
Arterial blood gases sample
an average of 20 min
Silverman Andersen Respiratory Severity Score (SA-RSS)
Time Frame: an average of 20 min
SA-RSS to assess work of breathing after extubation.
an average of 20 min
Number of patients who experienced weaning failure
Time Frame: 48 hours
the need for non invasive ventilation or re-intubation due to any cause
48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2023

Primary Completion (Estimated)

November 25, 2024

Study Completion (Estimated)

December 25, 2024

Study Registration Dates

First Submitted

May 10, 2023

First Submitted That Met QC Criteria

May 18, 2023

First Posted (Actual)

May 19, 2023

Study Record Updates

Last Update Posted (Actual)

July 16, 2024

Last Update Submitted That Met QC Criteria

July 13, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature

Clinical Trials on diaphragmatic tissue Doppler imaging,dTDI

Subscribe